Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 64 (3) , 992-1003
- https://doi.org/10.1046/j.1523-1755.2003.00154.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Differential activities of 1α,25-dihydroxy-16-ene-vitamin D3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosisSteroids, 2001
- Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidismKidney International, 2000
- In vitro suppression of parathyroid hormone secretion by 22-oxa-calcitriol in human parathyroid hyperplasia due to uraemiaNephrology, 1998
- Direct injections of calcitriol into enlarged parathyroid glands in chronic dialysis patients with severe parathyroid hyperfunctionNephrology, 1995
- Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patientsKidney International, 1994
- Regulation of calcitriol receptor and its mRNA in normal and renal failure ratsKidney International, 1994
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- Regulation of parathyroid hormone synthesis in chronic renal failure in ratsKidney International, 1991
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980